The Utility of the Combined Use of 123i-Fp-Cit and 123i-Mibg Myocardial Scintigraphy in Differentiating Parkinson’s Disease From Other Parkinsonian Syndromes

Yonago Acta Medica - Japan
doi 10.33160/yam.2018.06.004
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Tottori University Faculty of Medicine

Related search

The Utility of the Combination of a SPECT Study With [123i]-Fp-Cit of Dopamine Transporters and [123i]-Mibg Myocardial Scintigraphy in Differentiating Parkinson Disease From Other Degenerative Parkinsonian Syndromes

Nuclear Medicine Communications
MedicineNuclear MedicineRadiologyImaging
2017English

Is 123i-Mibg Cardiac Scintigraphy a Surrogate Marker for Parkinson’s Disease?

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2009English

Importance of 123i-Ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson’s Disease

Neurologia Medico-Chirurgica
SurgeryNeurology
2016English

123i-Mibg Scintigraphy and 18f-FDG PET in Neuroblastoma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

123i-mIBG Scintigraphy: Clinical Tool for Assessing Renal Sympathetic Activity?

Journal of Nuclear Cardiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2016English

123i-Methyljodbenzylguanidin- (MIBG-) Szintigraphie

Der Pathologe
Forensic MedicinePathology
2007English

Extraction, Selection and Comparison of Features for an Effective Automated Computer-Aided Diagnosis of Parkinson’s Disease Based on [123i]fp-Cit SPECT Images

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2017English

Myocardial Iodine-123-Metaiodobenzylguanidine (123i-Mibg) Imaging in Brugada Syndrome * Response

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing Between Parkinson’s Disease and Atypical Parkinsonian Syndromes

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy